Literature DB >> 10390648

7TM receptors: the splicing on the cake.

G J Kilpatrick1, F M Dautzenberg, G R Martin, R M Eglen.   

Abstract

Within a given family of seven transmembrane domain (7TM) receptors, functional diversity is most often afforded by the existence of multiple receptor subtypes, each encoded by a distinct gene. However, it is now clear that the existence of introns in genes encoding some members of a receptor family provides scope for additional diversity by virtue of splicing events that result in the formation of different receptor mRNAs and consequently distinct receptor isoforms. A large number of 7TM receptor splice variants have now been shown to exist. In this article, the current data on alternatively spliced variants for hormone and neurotransmitter 7TMs are reviewed, their potential physiological importance considered and some of the issues pertaining to the classification and nomenclature of receptor isoforms produced in this way are addressed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10390648     DOI: 10.1016/s0165-6147(99)01355-3

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  23 in total

1.  From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs.

Authors:  A V Terskikh; M C Easterday; L Li; L Hood; H I Kornblum; D H Geschwind; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 2.  Alternative splicing of G protein-coupled receptors: physiology and pathophysiology.

Authors:  Danijela Markovic; R A John Challiss
Journal:  Cell Mol Life Sci       Date:  2009-07-23       Impact factor: 9.261

Review 3.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

Review 4.  Signaling from novel splice variants of hormone receptors in cancer.

Authors:  Wei-Qun Ding; Laurence J Miller
Journal:  Int J Gastrointest Cancer       Date:  2002

5.  Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results.

Authors:  Scott H Long; Marc J Berna; Michelle Thill; Andrea Pace; Tapas K Pradhan; K Martin Hoffmann; Jose Serrano; Robert T Jensen
Journal:  J Clin Endocrinol Metab       Date:  2007-08-21       Impact factor: 5.958

6.  Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RS.

Authors:  Chaohong Sun; Danying Song; Rachel A Davis-Taber; Leo W Barrett; Victoria E Scott; Paul L Richardson; Ana Pereda-Lopez; Marie E Uchic; Larry R Solomon; Marc R Lake; Karl A Walter; Philip J Hajduk; Edward T Olejniczak
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

7.  Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor.

Authors:  Hippokratis Kiaris; Ioulia Chatzistamou; Andrew V Schally; Gabor Halmos; Jozsef L Varga; Helen Koutselini; Anastasios Kalofoutis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-16       Impact factor: 11.205

8.  Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants.

Authors:  T Benned-Jensen; M M Rosenkilde
Journal:  Br J Pharmacol       Date:  2010-02-08       Impact factor: 8.739

Review 9.  Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management.

Authors:  Folabomi A Oladosu; William Maixner; Andrea G Nackley
Journal:  Mayo Clin Proc       Date:  2015-08       Impact factor: 7.616

Review 10.  Group II metabotropic glutamate receptors and schizophrenia.

Authors:  José L Moreno; Stuart C Sealfon; Javier González-Maeso
Journal:  Cell Mol Life Sci       Date:  2009-08-26       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.